Skip to main content

Table 1 Demographics

From: Augmentation index and aortic stiffness in bicuspid aortic valve patients with non-dilated proximal aortas

Descriptives BAV TAV p-value
Age 46.5 ± 11.6 46.3 ± 15.1 0.97
Males (n, %) 6 (60%) 10 (77%) 0.40
Height (in) 66.0 ± 4.2 70.0 ± 3.5 0.02*
Weight (lbs) 188.9 ± 52.9 180.3 ± 48.9 0.69
Body mass index 30.1 ± 6.8 25.8 ± 5.8 0.10
Body surface area (m3) 1.98 ± 0.32 1.99 ± 0.32 0.93
Systolic blood pressure (mmHg) 118.3 ± 14.4 120.7 ± 13.4 0.69
Diastolic blood pressure (mmHg) 71.7 ± 11.6 70.2 ± 7.9 0.72
Pulse pressure (mmHg) 46.6 ± 11.4 50.6 ± 13.0 0.46
Mean arterial pressure (mmHg) 87.2 ± 11.4 87.0 ± 7.9 0.97
Heart rate (bpm) 64.1 ± 6.4 62.4 ± 12.6 0.70
Ejection fraction (%) 59.0 ± 3.1 58.5 ± 3.2 0.67
Aortic root diameter (cm) 3.14 ± 0.52 3.06 ± 0.34 0.75
Aortic root index (cm/m3) 1.59 ± 0.18 1.56 ± 0.26 0.69
Ascending aortic diameter (cm) 3.24 ± 0.46 2.87 ± 0.46 0.07
Ascending aortic index (cm/m3) 1.67 ± 0.35 1.45 ± 0.20 0.40
Aortic stenosis: mild (n, %) 5 (50%) None -
Peak aortic velocity (cm/sec) 217.5 ± 43.3 174.4 ± 45.8 0.001*
Peak wall shear rate (sec-1) 285.1 ± 18.9 180.1 ± 20.7 0.001*
Aortic insufficiency: 3 (30%) 2 (15%) 0.02*
Trace (n, %) 4 (40%) 1 (7.7%)
Mild (n, %)
Risk factors (n)
Hypertension 5 (50%) 5 (38%) 0.60
Hypercholesterolemia 4 (40%) 6 (46%) 0.85
Coronary artery disease 1 (10%) 2 (15%) 0.20
Tobacco use 1 (10%) 3 (23%) 0.72
Diabetes mellitus 1 (10%) 1 (7.7%) 0.44
Medications (n)
ASA 4 (40%) 2 (15%) 0.72
Anti-coagulants 1 (10%) 2 (15%) 0.20
Beta-blockers 5 (50%) 3 (23%) 0.72
ACE inhibitors/ARB 3 (30%) 3 (23%) 0.42
Statins 3 (30%) 2 (15%) 0.85
  1. Shown are the mean ± standard deviation of the mean.